ASH2 like histone lysine methyltransferase complex subunit pseudogene 3 (ASH2LP3)

ASH2L pseudogene 3 (ASH2LP3) is a pseudogene based on its designation and nomenclature. It is not known to encode a functional protein, nor does it possess known biological activity, therapeutic relevance, or molecular interactions. It is related by sequence to the ASH2L (ASH2 like, histone lysine methyltransferase complex subunit) gene, which encodes a core component of histone methyltransferase complexes involved in histone modification and gene regulation[3][4]. However, pseudogenes do not produce functional proteins and thus are generally not considered molecular drug targets. Key notes: - There is no evidence in available literature or databases connecting ASH2L pseudogene 3 to any protein product, therapeutic mechanisms, or disease relevance. - The functional ASH2L protein is a core component of histone methyltransferase complexes, but ASH2L pseudogene 3 itself does not have a role in these complexes or associated biological functions[3][4]. - Pseudogenes can sometimes be transcribed or have regulatory RNA functions, but no such role is described for ASH2L pseudogene 3 in current sources. Given these findings, ASH2L pseudogene 3 is not a therapeutic target, and its inclusion in drug-targeting or biomarker lists would be incorrect. The inquiry appears to be based on a non-functional or non-coding gene rather than a relevant therapeutic or molecular target.

Other names

ASH2LP3ASH2L pseudogene 3ash2 (absent, small, or homeotic)-like pseudogene